Replimune
1D
1W
1M
3M
1Y
5Y
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Replimune and other ETFs, options, and stocks.About REPL
Replimune Group, Inc. is a clinical-stage biotechnology company, which engages in the development of oncolytic immunotherapy product candidates through immulytic platform. Its product candidates include RP1, RP2, and RP3.
CEOPhilip Astley-Sparke
CEOPhilip Astley-Sparke
Employees206
Employees206
HeadquartersWoburn, Massachusetts
HeadquartersWoburn, Massachusetts
Founded2015
Founded2015
Employees206
Employees206
REPL Key Statistics
Market cap1.29B
Market cap1.29B
Price-Earnings ratio—
Price-Earnings ratio—
Dividend yield—
Dividend yield—
Average volume503.63K
Average volume503.63K
High today$26.41
High today$26.41
Low today$25.64
Low today$25.64
Open price$25.98
Open price$25.98
Volume354.49K
Volume354.49K
52 Week high$29.41
52 Week high$29.41
52 Week low$13.05
52 Week low$13.05
Analyst ratings
100%
of 9 ratingsBuy
100%
Hold
0%
Sell
0%
REPL Earnings
-$0.79
-$0.53
-$0.26
$0.00
Q1 FY22
Q2 FY22
Q3 FY22
Q4 FY22
Q1 FY23
Q2 FY23
Q3 FY23
Estimated-$0.75 per share
Estimated-$0.75 per share
ActualExpected Feb 10, Pre-Market
ActualExpected Feb 10, Pre-Market